Literature DB >> 1937961

Human tumor spontaneous metastasis in immunosuppressed newborn rats. II. Multiple selections of human melanoma metastatic clones and variants.

M Bailly1, J F Doré.   

Abstract

Using a recently developed model of human tumor spontaneous metastasis in immunosuppressed newborn rats, we selected variants with different metastatic abilities from the human melanoma cell line M4Be. We used 4 in vivo selection approaches, by direct serial tumor transplantations or by techniques involving in vitro reculture of the cells recovered from s.c. tumors or lung and lymph-node metastases. In addition, 3 series of clones were derived in vitro from the M4Be cell line, either by limiting-dilution or by cloning in semi-solid agar and harvesting small and large colonies. A considerable amount of heterogeneity in tumorigenicity and metastatic ability was demonstrated among variants and clones following in vivo selections and in vitro cloning. Four main malignant phenotypes were identified among those expressed by the selected cells: poorly tumorigenic and poorly metastatic; poorly tumorigenic and highly metastatic; highly tumorigenic and poorly metastatic; and highly tumorigenic and highly metastatic. However, while malignant phenotype (i.e., tumorigenicity and metastatic ability) did not appear to be grossly influenced by in vitro cloning procedure, it appeared greatly influenced both by the in vivo selection procedure (direct transplantations or use of in vitro culture between the in vivo passages) and by the origin of the cells under selection (s.c. tumor or metastases). Our study provided us with a large panel of variants and clones with varying metastatic abilities, which represent a model of human melanoma spontaneous metastasis allowing the study of critical determinants in human tumor metastasis.

Entities:  

Mesh:

Year:  1991        PMID: 1937961     DOI: 10.1002/ijc.2910490520

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Accumulation of heparan sulfate in the culture of human melanoma cells with different metastatic ability.

Authors:  M Moczar; F Caux; M Bailly; O Berthier; J F Doré
Journal:  Clin Exp Metastasis       Date:  1993-11       Impact factor: 5.150

2.  Gangliosides protect human melanoma cells from ionizing radiation-induced clonogenic cell death.

Authors:  C P Thomas; A Buronfosse; V Combaret; S Pedron; B Fertil; J Portoukalian
Journal:  Glycoconj J       Date:  1996-06       Impact factor: 2.916

3.  Monoclonal antibody accumulation in experimental and spontaneous lung metastases of human malignant melanoma in rodents.

Authors:  U Schmid; M Bailly; O Fodstad; H Bihl; S Matzku
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

4.  Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion.

Authors:  O Berthier-Vergnes; M El Kharbili; A de la Fouchardière; T Pointecouteau; P Verrando; A Wierinckx; J Lachuer; F Le Naour; J Lamartine
Journal:  Br J Cancer       Date:  2010-11-16       Impact factor: 7.640

5.  The gangliosides as a possible molecular coupling factor between the proportion of radiosensitive cells in vitro and the metastatic potential in vivo within a human melanoma cell line.

Authors:  C P Thomas; A Buronfosse; J Portoukalian; B Fertil
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Tspan8 Drives Melanoma Dermal Invasion by Promoting ProMMP-9 Activation and Basement Membrane Proteolysis in a Keratinocyte-Dependent Manner.

Authors:  Manale El Kharbili; Muriel Cario; Nicolas Béchetoille; Catherine Pain; Claude Boucheix; Françoise Degoul; Ingrid Masse; Odile Berthier-Vergnes
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639

7.  DNA methylome combined with chromosome cluster-oriented analysis provides an early signature for cutaneous melanoma aggressiveness.

Authors:  Arnaud Carrier; Cécile Desjobert; Loic Ponger; Laurence Lamant; Matias Bustos; Jorge Torres-Ferreira; Rui Henrique; Carmen Jeronimo; Luisa Lanfrancone; Audrey Delmas; Gilles Favre; Antoine Daunay; Florence Busato; Dave S B Hoon; Jorg Tost; Chantal Etievant; Joëlle Riond; Paola B Arimondo
Journal:  Elife       Date:  2022-09-20       Impact factor: 8.713

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.